TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Buprenorphine/therapeutic use
KW - Humans
KW - Opiate Substitution Treatment
KW - Opioid-Related Disorders/drug therapy
KW - Practice Patterns, Physicians'/statistics & numerical data
KW - Primary Health Care/statistics & numerical data
KW - Research Design
KW - Review Literature as Topic
KW - Health services administration & management
KW - Substance misuse
KW - buprenorphine
KW - opioid agonist treatment
KW - Public Health
KW - scoping review
AU - P. Leece
AU - T. Khorasheh
AU - K. Corace
AU - C. Strike
AU - A. M. Bayoumi
AU - S. Taha
AU - E. Marks
AU - B. Pach
AU - K. Ahamad
AU - E. Grennell
AU - M. Holowaty
AU - H. Manson
AU - S. E. Straus
A1 - 
AD - Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, Ontario, Canada Pamela.leece@oahpp.ca.; Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, Ontario, Canada.; Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.; Canadian Centre on Substance Use and Addiction, Ottawa, Ontario, Canada.; Knowledge Services, Public Health Ontario, Toronto, Ontario, Canada.; Knowledge Services, Public Health Ontario, Toronto, Ontario, Canada.; British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada.; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.; Department of Family Medicine, Queen's University, Kingston, Ontario, Canada.; Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, Ontario, Canada.; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada.
BT - BMJ open
C5 - Education & Workforce; Opioids & Substance Use
CP - 12
DO - 10.1136/bmjopen-2019-032285
IS - 12
JF - BMJ open
LA - eng
M1 - Journal Article
PB - . Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ
PY - 2019
SN - 2044-6055; 2044-6055
SP - 2019
EP - 032285
EP - e032285+
T1 - Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
T2 - BMJ open
TI - Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
U1 - Education & Workforce; Opioids & Substance Use
U2 - 31843837
U3 - 10.1136/bmjopen-2019-032285
VL - 9
VO - 2044-6055; 2044-6055
Y1 - 2019
Y2 - Dec 15
ER -